Johnson & Johnson
(UKEX:JNJ)
₴
5947
0 (0%)
Market Cap: 14.82 Til
Enterprise Value: 15.47 Til
PE Ratio: 24.01
PB Ratio: 4.98
GF Score: 84/100 Johnson & Johnson at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2021 / 04:20PM GMT
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Okay. So I think we're back. Thanks, everyone, for joining us. Sorry for the late start here. We had a little -- a few technical issues getting everyone together, but we're here now. My name is Matt Miksic. I cover medical devices here at Credit Suisse. And I'm very pleased to have with us today, Ashley McEvoy, Executive Vice President, World Chair of J&J's Medical Device business. Ashley, thanks so much for taking the time to join us.
Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Medical Devices
Yes, it's a pleasure to be here, Matt. Thanks for having me.
Questions & Answers
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst
© -
Pleasure is all ours. So I thought it might be a reasonable place to start. It seems like where every conversation starts this quarter is just around the environment.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot